IDEA Collider: Innovation & Asymmetric Learning in Pharma
IDEA Pharma, SAI MedPartners
60 episodes
1 month ago
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
All content for IDEA Collider: Innovation & Asymmetric Learning in Pharma is the property of IDEA Pharma, SAI MedPartners and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
We are excited to tell you more about the IDEA Pharma and Exploristics partnership.
IDEA’s COO, Jacqui Barendregt, asked Exploristics Founder and CEO Aiden Flynn five key questions about the innovative service model and, most importantly, the value to the pharmaceutical industry this newly formed partnership will bring.
In this engaging conversation, we delve into the world of pharmaceutical innovation and collaboration. Our guest, Dr. Nedim Pipic, a pharmaceutical expert specializing in mental and retinal health, shares his journey and passion for making a difference.
Quitting is a valuable skill. It’s important for dealing with uncertainty, yet we are quite bad at exercising it. It should not be just about sticking to things. Quitting is also good, particularly when we have to start most things. Persisting at something when it’s worthwhile is definitely a good character trait but persisting at something when it’s no longer worthwhile is not a good character trait. Calibrate around the notion, “is it worthwhile to stick? "
The speed of Recursion is remarkable in delivering a value proposition. Michael Secora, Chief Financial Officer at Recursion, expounds on data relatability, building various data sets, and leveraging data sets to build a next-generation biopharmaceutical company! Moreover, he shares tips on standing out amongst competitors and what differentiates Recursion from other AI discovery companies.
IDEA Collider: Innovation & Asymmetric Learning in Pharma
IDEA Collider explores how asymmetric learning drives bold innovation in the pharmaceutical and life sciences industries. Hosted by Mike Rea, CEO of IDEA Pharma & Head of Strategy and Thought Leadership at SAI MedPartners, the podcast features conversations with top thinkers, scientists, and strategists who challenge the status quo to spark real progress in drug development, biotech, and healthcare.
Each episode dives into how organizations can make smarter decisions earlier, reimagine R&D, and unlock competitive advantage through differentiated thinking.
Questions We Explore
* What is asymmetric learning, and how does it fuel pharma innovation?
* Why do some organizations outpace others—and what can we learn from them?
* How can we overcome barriers to meaningful progress in healthcare?
* What’s broken in traditional innovation models—and how do we fix it?
🎧 Listen and subscribe on all major platforms.
